Martin Unger
Vienna, 1190, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Pharmacokinetics of Landiolol and Its Metabolite M1 During Renal Replacement Therapy in Septic Shock Patients: A Sub-Study of the Landi-SEP Trial.
Journal: European journal of drug metabolism and pharmacokinetics
Published: October 07, 2025
A multicentre observational study on landiolol use, efficacy, and safety in European patients with supraventricular arrhythmia (Landi-UP).
Journal: European heart journal. Acute cardiovascular care
Published: August 04, 2025
Heart Rate Control with Landiolol Hydrochloride in Infants and Neonates During Cardiac Surgery.
Journal: Pediatric cardiology
Published: December 20, 2024
Landiolol is effective and safe in paediatric supraventricular tachycardia: evidence from a European prospective multicentre open-label phase III study (LANDI-PED).
Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Published: November 19, 2024
Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP).
Journal: Intensive care medicine
Published: March 12, 2024
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.
Journal: Annals of hematology
Published: January 12, 2024
Open-Label Two-Dose Pilot Study of Landiolol for the Treatment of Atrial Fibrillation/Atrial Flutter in Caucasian Patients.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: December 10, 2019
Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial.
Journal: Trials
Published: June 05, 2018
Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients.
Journal: Antimicrobial agents and chemotherapy
Published: November 13, 2016
Doripenem Treatment during Continuous Renal Replacement Therapy.
Journal: Antimicrobial agents and chemotherapy
Published: July 29, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026